ELEVATED LEVELS OF ACTIVITIES OF BETA-HEXOSAMINIDASE AND ALPHA-MANNOSIDASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS

被引:11
|
作者
LUGERING, N
STOLL, R
SIEKMANN, A
FAULHABER, J
HEESE, C
DIETRICH, O
KUCHARZIK, T
BUSCH, H
HASILIK, A
DOMSCHKE, W
机构
[1] UNIV MUNSTER,DEPT MED D,D-48129 MUNSTER,GERMANY
[2] UNIV MUNSTER,DEPT BIOCHEM & PATHOBIOCHEM,D-48129 MUNSTER,GERMANY
来源
JOURNAL OF INFECTIOUS DISEASES | 1995年 / 171卷 / 03期
关键词
D O I
10.1093/infdis/171.3.683
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine their value as markers of the clinical stage of human immunodeficiency virus (HIV) disease, plasma activities of lysosomal glycosidases were determined in the plasma of 97 HIV-infected patients: molecular forms of cathepsin D were characterized by Western blot to examine the mode of enzyme release. In patients with Centers for Disease Control and Prevention stage II and III of HIV disease, plasma activity of beta-hexosaminidase was significantly increased. In patients with stage III infection, alpha-mannosidase activity was also significantly increased and cathepsin D was elevated and present only in its premature form. Thus, determination of plasma activities of beta-hexosaminidase and alpha-mannosidase in HIV-positive persons may be useful for distinguishing the clinical stage of disease. The elevation of precursors of cathepsin D in patients with stage III HIV disease indicates that secretion of lysosomal enzymes rather than leakage of enzymes from damaged cells is markedly elevated.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 50 条
  • [21] Syphilitic uveitis in human immunodeficiency virus-infected patients
    Shalaby, IA
    Dunn, JP
    Semba, RD
    Jabs, DA
    ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (04) : 469 - 473
  • [22] Cochlear implantation in human immunodeficiency virus-infected patients
    Roland, JT
    Alexiades, G
    Jackman, AH
    Hillman, D
    Shapiro, W
    OTOLOGY & NEUROTOLOGY, 2003, 24 (06) : 892 - 895
  • [23] Joint replacement in human immunodeficiency virus-infected patients
    Wang, Ta-I
    Chen, Cheng-Fong
    Chen, Wei-Ming
    Chiang, Chao-Ching
    Huang, Ching-Kuei
    Liu, Chien-Lin
    Chen, Tain-Hsiung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2012, 75 (11) : 595 - 599
  • [24] ANORECTAL LESIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    PUYMONTBRUN, T
    DENIS, J
    GANANSIA, R
    MATHONIERE, F
    LEMARCHAND, N
    ARNOUSDUBOIS, N
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1992, 7 (01) : 26 - 30
  • [25] MANAGEMENT OF SYPHILIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    HOOK, EW
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05): : 477 - 479
  • [26] Cardiovascular manifestations in human immunodeficiency virus-infected patients
    Khunnawat, Chotikorn
    Mukeji, Siddharth
    Havlichek, Daniel, Jr.
    Touma, Rabih
    Abela, George S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (05): : 635 - 642
  • [27] TRANSFUSION PRACTICES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    POPOVSKY, MA
    BENSON, K
    GLASSMAN, AB
    HUME, H
    OBERMAN, HA
    PISCIOTTO, PT
    ANDERSON, KC
    TRANSFUSION, 1995, 35 (07) : 612 - 616
  • [28] OCULAR TOXOPLASMOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    COCHEREAUMASSIN, I
    LEHOANG, P
    LAUTIERFRAU, M
    ZERDOUN, E
    ZAZOUN, L
    ROBINET, M
    MARCEL, P
    GIRARD, B
    KATLAMA, C
    LEPORT, C
    ROZENBAUM, W
    COULAUD, JP
    GENTILINI, M
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 114 (02) : 130 - 135
  • [29] Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients
    Hernandez, LV
    Gilson, I
    Jacobson, J
    Affi, A
    Puetz, TR
    Dindzans, VJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (10) : 1627 - 1632
  • [30] Malignant syphilis in human immunodeficiency virus-infected patients
    Chang, Wei-Ting
    Hsieh, Tsung-Ting
    Wu, Yu-Hung
    DERMATOLOGICA SINICA, 2015, 33 (01) : 21 - 25